Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 17339864)

1.

Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.

Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC, Markowitz JS.

Clin Pharmacol Ther. 2007 Mar;81(3):346-53.

2.

Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans.

Patrick KS, Straughn AB, Reeves OT 3rd, Bernstein H, Bell GH, Anderson ER, Malcolm RJ.

Drug Metab Dispos. 2013 Jan;41(1):197-205. doi: 10.1124/dmd.112.048595. Epub 2012 Oct 25.

3.

Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.

Bell GH, Novak AJ, Griffin WC 3rd, Patrick KS.

J Pharm Sci. 2011 Jul;100(7):2966-78. doi: 10.1002/jps.22476. Epub 2011 Jan 14.

4.
5.

A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.

Teo SK, Scheffler MR, Wu A, Stirling DI, Thomas SD, Stypinski D, Khetani VD.

J Clin Pharmacol. 2004 Feb;44(2):173-8.

PMID:
14747426
6.

Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

Patrick KS, Corbin TR, Murphy CE.

J Pharm Sci. 2014 Dec;103(12):3834-42. doi: 10.1002/jps.24202. Epub 2014 Oct 9. Review.

7.

Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactions.

Zhu HJ, Patrick KS, Markowitz JS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Apr 1;879(11-12):783-8. doi: 10.1016/j.jchromb.2011.02.033. Epub 2011 Feb 25.

8.

Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate.

Koehm M, Kauert GF, Toennes SW.

Arzneimittelforschung. 2010;60(5):238-44.

PMID:
20533759
9.

Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Markowitz JS, Straughn AB, Patrick KS, DeVane CL, Pestreich L, Lee J, Wang Y, Muniz R.

Clin Pharmacokinet. 2003;42(4):393-401.

PMID:
12648029
11.

Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol.

Markowitz JS, DeVane CL, Boulton DW, Nahas Z, Risch SC, Diamond F, Patrick KS.

Drug Metab Dispos. 2000 Jun;28(6):620-4.

12.

Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man.

Tuerck D, Wang Y, Maboudian M, Wang Y, Sedek G, Pommier F, Appel-Dingemanse S.

Int J Clin Pharmacol Ther. 2007 Dec;45(12):662-8.

PMID:
18184535
13.

Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in Beagle dogs.

Lavy E, Prise U, Soldani G, Neri D, Brandriss N, Bar Chaim A, Giorgi M.

Vet J. 2011 Sep;189(3):336-40. doi: 10.1016/j.tvjl.2010.07.007. Epub 2010 Aug 8.

PMID:
20696604
14.

Methylphenidate bioavailability from two extended-release formulations.

González MA, Pentikis HS, Anderl N, Benedict MF, DeCory HH, Dirksen SJ, Hatch SJ.

Int J Clin Pharmacol Ther. 2002 Apr;40(4):175-84.

PMID:
11996212
15.

Effects of food on the pharmacokinetics of methylphenidate.

Midha KK, McKay G, Rawson MJ, Korchinski ED, Hubbard JW.

Pharm Res. 2001 Aug;18(8):1185-9.

PMID:
11587491
16.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
17.

Pharmacokinetics of coadministration of guanfacine extended release and methylphenidate extended release.

Roesch B, Corcoran M, Haffey M, Stevenson A, Wang P, Purkayastha J, Martin P, Ermer J.

Drugs R D. 2013 Mar;13(1):53-61. doi: 10.1007/s40268-013-0009-5.

18.

Pharmacokinetics of methylphenidate following two oral formulations (immediate and sustained release) in the dog.

Giorgi M, Prise U, Soldani G, Neri D, Lavy E.

Vet Res Commun. 2010 Jun;34 Suppl 1:S73-7. doi: 10.1007/s11259-010-9388-z.

PMID:
20454855
19.

In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.

Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M.

Biopharm Drug Dispos. 2004 Mar;25(2):91-8.

PMID:
14872557
20.

Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.

Pierce D, Dixon CM, Wigal SB, McGough JJ.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):355-64. doi: 10.1089/cap.2007.0148.

PMID:
18759645
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk